Survival advantage from second line immunotherapy in stage IV Non Small Cell Lung Cancer (NSCLC) patients

Postgraduate Thesis uoadl:2838370 271 Read counter

Unit:
Κατεύθυνση Καρκίνος Πνεύμονα: Σύγχρονη Κλινικοεργαστηριακή Προσέγγιση και Έρευνα
Library of the School of Health Sciences
Deposit date:
2018-12-28
Year:
2018
Author:
Maragkoudakis Christos
Supervisors info:
Κωνσταντίνος Ν. Συρίγος, Καθηγητής, Ιατρική Σχολή, ΕΚΠΑ
Μπακάκος Πέτρος, Αναπληρωτής Καθηγητής, Ιατρική Σχολή, ΕΚΠΑ
Πουλάκου Γαρυφαλλιά, Καθηγήτρια, Ιατρική Σχολή, ΕΚΠΑ
Original Title:
Survival advantage from second line immunotherapy in stage IV Non Small Cell Lung Cancer (NSCLC) patients
Languages:
Greek
Translated title:
Survival advantage from second line immunotherapy in stage IV Non Small Cell Lung Cancer (NSCLC) patients
Summary:
Metanalysis of studies in NSCLC patients who had immunotherapy versus chemotherapy
Main subject category:
Health Sciences
Keywords:
Immunotherapy, Chemotherapy, NSCLC
Index:
No
Number of index pages:
0
Contains images:
Yes
Number of references:
98
Number of pages:
52
File:
File access is restricted only to the intranet of UoA.

ΔΙΠΛΩΜΑΤΙΚΗ ΜΑΡΑΓΚΟΥΔΑΚΗΣ..pdf
916 KB
File access is restricted only to the intranet of UoA.